Literature DB >> 25662779

Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.

Zaher Fanari1, Sandra A Weiss2, Wei Zhang3, Seema S Sonnad3, William S Weintraub4.   

Abstract

OBJECTIVE: To compare outcomes of percutaneous coronary intervention (PCI) with drug eluting stent (DES) and Coronary Artery Bypass Grafting (CABG) in patients with multivessel Coronary Artery Disease (CAD) using data from randomized controlled trials (RCT).
BACKGROUND: PCI and CABG are established strategies for coronary revascularization in the setting of ischemic heart disease. Multiple RCTs have compared outcomes of the two modalities in patients with multivessel CAD.
METHODS: We did a meta-analysis from six RCTs in the contemporary era comparing the effectiveness of PCI with DES to at 1 year, 2 years and 5 years respectively.
RESULTS: Compared to CABG, at one year PCI was associated with a significantly higher incidence of TVR (RR=2.31; 95% CI: [1.80-2.96]; P=<0.0001), lower incidence of stroke (RR=0.35; 95% CI: [0.19-0.62]; P=0.0003), and no difference in death (RR=1.02; 95% CI: [0.77-1.36]; P=0.88) or MI (RR=1.16; 95% CI: [0.72-1.88]; P=0.53). At 5 years, PCI was associated with a higher incidence of death (RR=1.3; 95% CI: [1.10-1.54]; P=0.0026) and MI (RR=2.21; 95% CI: [1.75-2.79]; P=<0.0001). While the higher incidence of MI with PCI was noticed in both diabetic and non-diabetics, death was increased mainly in diabetic patients.
CONCLUSION: In patients with multi-vessel CAD, PCI with DES is associated with no significant difference in death or MI at 1 or 2 years. However at 5 years, PCI is associated with higher incidence of death and MI.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary artery bypass grafting; Drug eluting stents; Percutaneous coronary intervention; Randomized control trials

Mesh:

Year:  2015        PMID: 25662779      PMCID: PMC4398629          DOI: 10.1016/j.carrev.2015.01.002

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  29 in total

Review 1.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

Authors:  D Moher; D J Cook; S Eastwood; I Olkin; D Rennie; D F Stroup
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results.

Authors:  Whady Hueb; Paulo R Soares; Bernard J Gersh; Luiz A M César; Protásio L Luz; Luiz B Puig; Eulógio M Martinez; Sergio A Oliveira; José A F Ramires
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

4.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).

Authors:  A Rodriguez; E Mele; E Peyregne; F Bullon; N Perez-Baliño; M I Liprandi; I F Palacios
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

7.  Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.

Authors:  Arie Pieter Kappetein; Stuart J Head; Marie-Claude Morice; Adrian P Banning; Patrick W Serruys; Friedrich-Wilhelm Mohr; Keith D Dawkins; Michael J Mack
Journal:  Eur J Cardiothorac Surg       Date:  2013-02-14       Impact factor: 4.191

8.  Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; A S Kosinski; R A Guyton; N J Lembo; W S Weintraub
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

9.  First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants.

Authors: 
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

10.  Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.

Authors:  Subodh Verma; Michael E Farkouh; Bobby Yanagawa; David H Fitchett; Muhammad R Ahsan; Marc Ruel; Sachin Sud; Milan Gupta; Shantanu Singh; Nandini Gupta; Asim N Cheema; Lawrence A Leiter; Paul W M Fedak; Hwee Teoh; David A Latter; Valentin Fuster; Jan O Friedrich
Journal:  Lancet Diabetes Endocrinol       Date:  2013-09-13       Impact factor: 32.069

View more
  8 in total

1.  Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.

Authors:  John K Roberts; Sunil V Rao; Linda K Shaw; Dianne S Gallup; Oscar C Marroquin; Uptal D Patel
Journal:  Am J Cardiol       Date:  2017-02-09       Impact factor: 2.778

2.  Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? -a review of the evidences on coronary artery disease.

Authors:  Cristiano Spadaccio; Umberto Benedetto
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 3.  Percutaneous Coronary Intervention with Stenting versus Coronary Artery Bypass Grafting in Stable Coronary Artery Disease.

Authors:  Ian C Glenn; Gabriele M Iacona; Abeel A Mangi
Journal:  Int J Angiol       Date:  2021-08-31

4.  Long-term survival after coronary bypass surgery and percutaneous coronary intervention.

Authors:  Per Mølstad; Rasmus Moer; Olaf Rødevand
Journal:  Open Heart       Date:  2016-10-24

Review 5.  Contemporary use of arterial and venous conduits in coronary artery bypass grafting: anatomical, functional and clinical aspects.

Authors:  G Cuminetti; S Gelsomino; S Curello; R Lorusso; J G Maessen; J C A Hoorntje
Journal:  Neth Heart J       Date:  2017-01       Impact factor: 2.380

6.  Comparison of Long-term Outcomes in Patients with Premature Triple-vessel Coronary Disease Undergoing Three Different Treatment Strategies: A Prospective Cohort Study.

Authors:  Jing-Jing Xu; Yin Zhang; Lin Jiang; Jian Tian; Lei Song; Zhan Gao; Xin-Xing Feng; Xue-Yan Zhao; Yan-Yan Zhao; Dong Wang; Kai Sun; Lian-Jun Xu; Ru Liu; Run-Lin Gao; Bo Xu; Lei Song; Jin-Qing Yuan
Journal:  Chin Med J (Engl)       Date:  2018-01-05       Impact factor: 2.628

7.  Revascularization strategies in patients with multivessel coronary artery disease: a Bayesian network meta-analysis.

Authors:  Jef Van den Eynde; Katrien Bomhals; Dries Noé; Xander Jacquemyn; Keir McCutcheon; Johan Bennett; John D Puskas; Wouter Oosterlinck
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01

8.  CABG versus PCI: What is the optimal strategy for multi-vessel disease?

Authors:  Ayush Kumar; Govinda Khatri; Mohammad Mehedi Hasan
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.